Brain imaging (resting-state fMRI) was used to measure how Semax affects the brain's default mode network — the set of regions active during rest and self-referential thought — in healthy volunteers. People who received Semax intranasally showed a larger volume of activity in the frontal portion of the default mode network compared to placebo, both 5 and 20 minutes after dosing. This is one of the first direct brain imaging studies of Semax, confirming that it produces measurable changes in neural network activity in healthy humans.
Lebedeva, I S; Panikratova, Ya R; Sokolov, O Yu; Kupriyanov, D A; Rumshiskaya, A D; Kost, N V; Myasoedov, N F